Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25979747 | 0.95 | GAA (0.33) | KDM4ETSHRTDP1CYP1A2CYP2C19 | |
| SCHEMBL25979845 | 0.93 | CYP1A2 (0.33) | KDM4ETSHRTDP1CYP1A2CYP2C19 | |
| SCHEMBL25979963 | 0.91 | KDM4E (0.32) | KDM4ETSHRTDP1CYP1A2CYP2C19 | |
| SCHEMBL25979795 | 0.86 | GAA (0.32) | KDM4ETSHRTDP1CYP1A2CYP2C19 | |
| SCHEMBL25979967 | 0.84 | CYP1A2 (0.33) | KDM4ETSHRTDP1CYP1A2CYP2C19 | |
| SCHEMBL25979911 | 0.84 | — | — | |
| SCHEMBL24098416 | 0.82 | CYP1A2 (0.37) | KDM4ETSHRTDP1CYP1A2CYP2C19 | |
| SCHEMBL25979914 | 0.82 | — | — | |
| SCHEMBL25979749 | 0.82 | — | — | |
| SCHEMBL25979563 | 0.81 | CYP1A2 (0.39) | KDM4ETSHRTDP1CYP1A2CYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230240128-A1 | COMPOUNDS FOR FORMING A PATTERNING COATING AND DEVICES INCORPORATING SAME | OTI LUMIONICS INC. (CA) | 2023-07-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230240128-A1 | COMPOUNDS FOR FORMING A PATTERNING COATING AND DEVICES INCORPORATING SAME | NONO, EPHA4, EPHA6 | KDM4E 368/4885TSHR 3282/4885TDP1 4468/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.